ERIS Lifescience

ERIS Lifesciences Ltd Quarterly Results

NSEBSE

₹1,438.3

(-1.81%)

Apr 30, 2025|02:34:58 PM

Invest wise with Expert advice

Financials

ConsolidatedStandalone

Select Period

Particulars (Rupees in Crores.)	Dec-2024	Sept-2024	Jun-2024	Mar-2024	Dec-2023
Gross Sales	722.12	738.95	715.59	547.27	483.48
Excise Duty	0	0	0	0	0
Net Sales	722.12	738.95	715.59	547.27	483.48
Other Operating Income	5.33	2.22	4.13	3.66	2.82
Other Income	4.22	4.55	1.64	15.15	4.2
Total Income	731.67	745.72	721.36	566.08	490.5
Total Expenditure	477.14	476.66	469.73	402.5	310.79
PBIDT	254.53	269.06	251.63	163.58	179.71
Interest	57.17	59.47	60.37	33.03	18.12
PBDT	197.36	209.59	191.26	130.55	161.59
Depreciation	81.2	80.48	75.94	53.9	45.72
Minority Interest Before NP	0	0	0	0	0
Tax	24.86	30.25	25.34	15.73	19.38
Deferred Tax	4.37	2.51	0.56	-18.71	-4.97
Reported Profit After Tax	86.93	96.35	89.42	79.63	101.46
Minority Interest After NP	3.3	4.76	6.24	8.67	-1.28
Net Profit after Minority Interest	83.63	91.59	83.18	70.96	102.74
Extra-ordinary Items	0	0	0	0	0
Adjusted Profit After Extra-ordinary item	83.63	91.59	83.18	70.96	102.74
EPS (Unit Curr.)	6.15	6.73	6.11	5.22	7.55
Book Value (Unit Curr.)	0	0	0	0	0
Dividend (%)	735	0	0	0	0
Equity	13.61	13.61	13.61	13.6	13.6
Public Shareholding (Number)	0	0	0	0	0
Public Shareholding (%)	0	0	0	0	0
Pledged/Encumbered - No. of Shares	0	0	0	0	0
Pledged/Encumbered - % in Total Promoters Holding	0	0	0	0	0
Pledged/Encumbered - % in Total Equity	0	0	0	0	0
Non Encumbered - No. of Shares	0	0	0	0	0
Non Encumbered - % in Total Promoters Holding	0	0	0	0	0
Non Encumbered - % in Total Equity	0	0	0	0	0
PBIDTM(%)	35.24	36.41	35.16	29.89	37.17
PBDTM(%)	27.33	28.36	26.72	23.85	33.42
PATM(%)	12.03	13.03	12.49	14.55	20.98